Skip to main content
News Jung 09.2021
AG Jung: Julia Steinberg, Timo Wadenpohl, Jun. Prof. Dr. Stephanie Jung
© Katharina Wislsperger / UKB

News categories: Publication

How danger signaling is amplified in Influenza A-virus infected cells

Young research goup around Cluster Member Stephanie Jung shows how danger signaling is amplified in Influenza A-virus infected cells.

Influenza virus-induced acute respiratory infections occur in all parts of the world and represent a constant disease-burden. While the seasonal epidemic outbreaks are caused by Influenza-subtypes A and B, only Influenza-A strains are reported to have caused pandemic spreads. Overall, Influenza-A infections account for 250,000 to 300,000 deaths p.a.

To protect us from microbial threats, the innate immune system provides several immune sensing receptors. These recognize foreign microbial molecules and induce an immunological response. RNA-viruses like Influenza-A and Hepatitis-C are detected by the intracellular receptor RIG-I (retinoic acid inducible gene I). RIG-I binds to double-stranded viral RNA and hairpin structures of viral genomes. Upon activation, the receptor multimerizes and ultimately induces the cellular release of antiviral cytokines.

In a previous publication, Stephanie Jung and colleagues already described the role of endogenous RNA in an amplified RIG-I activation: Recognition of viral RNA by oligoadenylate synthase leads to activation of RNase L, which cleaves endogenous ribosomal RNAs. The resulting fragment acts as endogenous RIG-I ligand (eRL) and thereby amplifies the RIG-I mediated response to the viral thread.

Stephanie Jung and her team now provide evidence that eRL is generated in Influenza-A infected cells. Further they could show that the activation of RIG-I by eRL is independent of the direct recognition of viral RNAs by the receptor. The work thereby provides the foundation for further research on the physiological function of eRLs and their role in other viral infections.

Remarkably, the paper was published only a few months into first-author Julia Steinbergs PhD project, who started her work with Stephanie Jung in April 2021. “Sometimes things just run perfectly – even in the lab” Julia states. It is important to enable young scientists to publish early on during their PhD, Stephanie Jung is convinced. “With her first publication in hand, Julia can now pursue her main project with the maximum freedom possible”.

It is also the first publication for Stephanie Jung as Junior Professor for Cellular Virology and member of the Cluster of Excellence Immunosensation2. As group leader at the institute of Cardiovascular Immunology, her research is focused on the identification of immune-activating viral RNAs and the role of extracellular vesicles in viral infections.


Participating institutions and funding

The project was funded by the German Research Foundation (DFG) under the Germany’s Excellence Strategy – EXC2151 – 390873048.


Publication

Julia Steinberg, Timo Wadenpohl, Stephanie Jung: The Endogenous RIG-I Ligand Is Generated in Influenza A-Virus Infected Cells. Viruses. https://www.mdpi.com/1999-4915/13/8/1564


Contact

Jun. Prof. Dr. Stephanie Jung

University Bonn

University Hospital Bonn

stephanie.jung@ukbonn.de

Related news

Dr. Ivana Jorgacevic und Prof. Dr. Rayk Behrendt have discovered that the inflammatory messenger substance interferon-alpha can trigger Sjögren's syndrome: The researchers in Bonn.

News categories: Publication

New test points to precision treatment for autoimmune condition

Interferon alpha is an inflammatory mediator that can cause Sjögren’s syndrome, an autoimmune disease. This is revealed in a recent study carried out by the University Hospital Bonn together with the University of Bonn, the University of Edinburgh and Newcastle University. Their findings, which have been published in the journal “Lancet Rheumatology,” could make it easier in the medium term to develop drugs to fight this chronic condition.
View entry
Precise Konsortium

News categories: Publication Honors & Funding

Making Cancer Cells More Predictable: PRECISE Aims to Forecast Therapeutically Actionable Vulnerabilities

Which genes and signaling pathways does a cancer cell require to survive? And which of these could serve as therapeutic targets? The pan-European initiative PRECISE aims to identify such vulnerabilities not only through labor-intensive laboratory experiments but also by predicting them using computational models. The UKB and the University of Bonn, represented by Prof. Dr. Maximilian Billmann and Prof. Dr. Jonathan Schmid-Burgk, are among the founding partners of the consortium. The scientific vision of the initiative has now been published in a commentary in Nature Genetics.
View entry
Bild

News categories: Publication

Focus on the Guardians of the Antibody Response

For the immune system to effectively combat pathogens, antibody responses must be precisely controlled. So-called follicular regulatory T cells (Tfr cells) play a key role in this process by limiting excessive immune responses and helping to maintain immune tolerance. Researchers at the University Hospital Bonn (UKB) and the University of Bonn have now developed a robust laboratory method that allows Tfr cells to be generated from precursor cells and studied in a targeted manner. The results were recently published in the journal Cellular & Molecular Immunology.
View entry

Back to the news overview